• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration.HIV-1 整合酶单体诱导与 LTR DNA 的特异性相互作用,以进行协同整合。
Biochemistry. 2011 Nov 15;50(45):9788-96. doi: 10.1021/bi201247f. Epub 2011 Oct 19.
2
Recombinant human immunodeficiency virus type 1 integrase exhibits a capacity for full-site integration in vitro that is comparable to that of purified preintegration complexes from virus-infected cells.重组人免疫缺陷病毒1型整合酶在体外表现出全位点整合能力,这与来自病毒感染细胞的纯化前整合复合物的整合能力相当。
J Virol. 2005 Jul;79(13):8208-16. doi: 10.1128/JVI.79.13.8208-8216.2005.
3
[Interactions of HIV-1 DNA heterocyclic bases with viral DNA].[人类免疫缺陷病毒1型DNA杂环碱基与病毒DNA的相互作用]
Mol Biol (Mosk). 2004 Sep-Oct;38(5):848-57.
4
Activity of recombinant HIV-1 integrase on mini-HIV DNA.重组HIV-1整合酶对微型HIV DNA的活性
Nucleic Acids Res. 1999 May 15;27(10):2202-10. doi: 10.1093/nar/27.10.2202.
5
Two-long terminal repeat (LTR) DNA circles are a substrate for HIV-1 integrase.两段长末端重复(LTR)DNA 环是 HIV-1 整合酶的底物。
J Biol Chem. 2019 May 17;294(20):8286-8295. doi: 10.1074/jbc.RA118.006755. Epub 2019 Apr 10.
6
Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.HIV长末端重复序列的改变以及HIV整合酶的改变对HIV整合酶的组装、活性和链转移抑制剂的结合产生不同影响。
J Biol Chem. 2007 Oct 26;282(43):31186-96. doi: 10.1074/jbc.M704935200. Epub 2007 Aug 21.
7
Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase.人类免疫缺陷病毒1型整合酶对逆转录病毒样DNA的协同整合
J Virol. 1995 Oct;69(10):6090-7. doi: 10.1128/JVI.69.10.6090-6097.1995.
8
Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA.使用病毒DNA的新型类似物探究HIV-1整合酶/DNA相互作用。
J Biol Chem. 2006 Apr 28;281(17):11530-40. doi: 10.1074/jbc.M512271200. Epub 2006 Feb 24.
9
Functional nucleotides of U5 LTR determining substrate specificity of prototype foamy virus integrase.决定原型泡沫病毒整合酶底物特异性的U5长末端重复序列的功能核苷酸
J Microbiol Biotechnol. 2008 Jun;18(6):1044-9.
10
HIV-1 integrase strand transfer inhibitors stabilize an integrase-single blunt-ended DNA complex.HIV-1 整合酶链转移抑制剂稳定整合酶-单链平末端 DNA 复合物。
J Mol Biol. 2011 Jul 29;410(5):831-46. doi: 10.1016/j.jmb.2011.01.043. Epub 2011 Feb 3.

引用本文的文献

1
A unified classification system for HIV-1 5' long terminal repeats.HIV-1 5' 长末端重复序列的统一分类系统。
PLoS One. 2024 May 2;19(5):e0301809. doi: 10.1371/journal.pone.0301809. eCollection 2024.
2
The Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario.整合酶:抗病毒方案中的关键酶概述。
Int J Mol Sci. 2023 Jul 29;24(15):12187. doi: 10.3390/ijms241512187.
3
Multimodal Functionalities of HIV-1 Integrase.HIV-1 整合酶的多模态功能。
Viruses. 2022 Apr 28;14(5):926. doi: 10.3390/v14050926.
4
Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis.整合酶 RNA 相互作用强调了整合酶在 HIV-1 病毒形态发生中的关键作用。
Elife. 2020 Sep 22;9:e54311. doi: 10.7554/eLife.54311.
5
Going beyond Integration: The Emerging Role of HIV-1 Integrase in Virion Morphogenesis.超越整合:HIV-1 整合酶在病毒形态发生中的新兴作用。
Viruses. 2020 Sep 9;12(9):1005. doi: 10.3390/v12091005.
6
Influence of the amino-terminal sequence on the structure and function of HIV integrase.HIV 整合酶结构与功能的氨基端序列影响
Retrovirology. 2020 Aug 31;17(1):28. doi: 10.1186/s12977-020-00537-x.
7
Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.HIV 整合酶的多方面功能及其抑制的治疗策略。
J Biol Chem. 2019 Oct 11;294(41):15137-15157. doi: 10.1074/jbc.REV119.006901. Epub 2019 Aug 29.
8
Cellular and molecular mechanisms of HIV-1 integration targeting.HIV-1 整合靶向的细胞和分子机制。
Cell Mol Life Sci. 2018 Jul;75(14):2491-2507. doi: 10.1007/s00018-018-2772-5. Epub 2018 Feb 7.
9
Retroviral intasomes arising.逆转录病毒内切体的出现。
Curr Opin Struct Biol. 2017 Dec;47:23-29. doi: 10.1016/j.sbi.2017.04.005. Epub 2017 Apr 28.
10
Retroviral integrase protein and intasome nucleoprotein complex structures.逆转录病毒整合酶蛋白和整合体核蛋白复合体结构。
World J Biol Chem. 2017 Feb 26;8(1):32-44. doi: 10.4331/wjbc.v8.i1.32.

本文引用的文献

1
Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1.连续删除整合酶(Gag-Pol)羧基末端会揭示出不同表型类别的缺陷 HIV-1。
J Virol. 2011 May;85(10):4654-66. doi: 10.1128/JVI.02374-10. Epub 2011 Mar 2.
2
HIV-1 integrase strand transfer inhibitors stabilize an integrase-single blunt-ended DNA complex.HIV-1 整合酶链转移抑制剂稳定整合酶-单链平末端 DNA 复合物。
J Mol Biol. 2011 Jul 29;410(5):831-46. doi: 10.1016/j.jmb.2011.01.043. Epub 2011 Feb 3.
3
Structural insights into the retroviral DNA integration apparatus.逆转录病毒 DNA 整合装置的结构见解。
Curr Opin Struct Biol. 2011 Apr;21(2):249-56. doi: 10.1016/j.sbi.2010.12.005. Epub 2011 Feb 1.
4
Structural biology of retroviral DNA integration.逆转录病毒 DNA 整合的结构生物学。
Virology. 2011 Mar 15;411(2):194-205. doi: 10.1016/j.virol.2010.12.008. Epub 2011 Jan 8.
5
The mechanism of retroviral integration from X-ray structures of its key intermediates.逆转录病毒整合的机制来自其关键中间体的 X 射线结构。
Nature. 2010 Nov 11;468(7321):326-9. doi: 10.1038/nature09517.
6
Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance.逆转录酶抑制剂的分子机制与病毒耐药性的进化。
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):20057-62. doi: 10.1073/pnas.1010246107. Epub 2010 Oct 28.
7
Physical trapping of HIV-1 synaptic complex by different structural classes of integrase strand transfer inhibitors.不同结构类型的整合酶链转移抑制剂对 HIV-1 突触复合物的物理捕获。
Biochemistry. 2010 Sep 28;49(38):8376-87. doi: 10.1021/bi100514s.
8
Structure-based modeling of the functional HIV-1 intasome and its inhibition.基于结构的功能性 HIV-1 整合酶三聚体模型及其抑制作用。
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15910-5. doi: 10.1073/pnas.1002346107. Epub 2010 Aug 23.
9
Retroviral intasome assembly and inhibition of DNA strand transfer.逆转录病毒内切体组装和 DNA 链转移抑制。
Nature. 2010 Mar 11;464(7286):232-6. doi: 10.1038/nature08784. Epub 2010 Jan 31.
10
Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase.HIV-1 整合酶 18 残基 C 末端尾部的生化和病毒学分析。
Retrovirology. 2009 Oct 19;6:94. doi: 10.1186/1742-4690-6-94.

HIV-1 整合酶单体诱导与 LTR DNA 的特异性相互作用,以进行协同整合。

The HIV-1 integrase monomer induces a specific interaction with LTR DNA for concerted integration.

机构信息

Institute for Molecular Virology, Saint Louis University Health Sciences Center, Saint Louis, Missouri 63104, United States.

出版信息

Biochemistry. 2011 Nov 15;50(45):9788-96. doi: 10.1021/bi201247f. Epub 2011 Oct 19.

DOI:10.1021/bi201247f
PMID:21992419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3212032/
Abstract

The assembly mechanism for the human immunodeficiency virus type 1 (HIV) synaptic complex (SC) capable of concerted integration is unknown. Molecular and structural studies have established that the HIV SC and prototype foamy virus (PFV) intasome contain a tetramer of integrase (IN) that catalyzes concerted integration. HIV IN purified in the presence of 1 mM EDTA and 10 mM MgSO(4) was predominately a monomer. IN efficiently promoted concerted integration of micromolar concentrations of 3'-OH recessed and blunt-ended U5 long terminal repeat (LTR) oligonucleotide (ODN) substrates (19-42 bp) into circular target DNA. Varying HIV IN to U5 DNA showed that an IN dimer:DNA end molar ratio of 1 was optimal for concerted integration. Integration activities decreased with an increasing length of the ODN, starting from the recessed 18/20 or 19/21 bp set to the 31/33 and 40/42 bp set. Under these conditions, the average fidelity for the HIV 5 bp host site duplication with recessed and blunt-ended substrates was 56%. Modifications of U5 LTR sequences beyond 21 bp from the terminus on longer DNA (1.6 kb) did not alter the ~32 bp DNaseI protective footprint, suggesting viral sequences beyond 21 bp were not essential for IN binding. The results suggest IN binds differentially to an 18/20 bp than to a 40/42 bp ODN substrate for concerted integration. The HIV IN monomer may be a suitable candidate for attempting crystallization of an IN-DNA complex in the absence or presence of strand transfer inhibitors.

摘要

人类免疫缺陷病毒 1 型 (HIV) 突触复合物 (SC) 的组装机制尚不清楚。分子和结构研究已经确立,HIV SC 和原型泡沫病毒 (PFV) 内合体包含一个四聚整合酶 (IN),它催化协同整合。在 1 mM EDTA 和 10 mM MgSO 4存在下纯化的 HIV IN 主要是单体。IN 有效地促进了微摩尔浓度的 3'-OH 凹陷和平齐末端 U5 长末端重复 (LTR) 寡核苷酸 (ODN) 底物 (19-42 bp) 与环状靶 DNA 的协同整合。改变 HIV IN 到 U5 DNA 表明,IN 二聚体:DNA 末端摩尔比为 1 时,协同整合最佳。随着 ODN 长度的增加,整合活性降低,从凹陷的 18/20 或 19/21 bp 开始,到 31/33 和 40/42 bp。在这些条件下,具有凹陷和平齐末端底物的 HIV 5 bp 宿主位点复制的平均保真度为 56%。在更长的 DNA(1.6 kb)上从末端开始的 U5 LTR 序列的修饰不会改变~32 bp 的 DNaseI 保护足迹,这表明 21 bp 以外的病毒序列对于 IN 结合不是必需的。结果表明,IN 与 18/20 bp 的结合不同于与 40/42 bp 的 ODN 底物的结合,用于协同整合。HIV IN 单体可能是在没有或存在链转移抑制剂的情况下尝试 IN-DNA 复合物结晶的合适候选物。